Flynt, L. K., Kenney, R. M., Zervos, M. J., & Davis, S. L. (2017). The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections. Infect Dis Ther.
Styl ChicagoFlynt, Lauren K., Rachel M. Kenney, Marcus J. Zervos, a Susan L. Davis. "The Safety and Economic Impact of Cefazolin Versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections." Infect Dis Ther 2017.
Citace podle MLAFlynt, Lauren K., Rachel M. Kenney, Marcus J. Zervos, a Susan L. Davis. "The Safety and Economic Impact of Cefazolin Versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus Aureus Bloodstream Infections." Infect Dis Ther 2017.